SK Plasma has been selected as Türkiye’s technology partner for a national plasma fractionation self-sufficiency project, securing a 15% stake in a joint venture and expanding its presence in the Turkish blood products market.
#YonhapInfomax #SKPlasma #Proturk #PlasmaFractionation #TurkeyMarket #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=92333
SK Plasma Selected as Partner for Türkiye’s National Plasma Fractionation Self-Sufficiency Project
SK Plasma has been selected as Türkiye’s technology partner for a national plasma fractionation self-sufficiency project, securing a 15% stake in a joint venture and expanding its presence in the Turkish blood products market.
SK Plasma has signed an MOU with Indonesia's sovereign wealth fund Danantara to invest in blood product manufacturing infrastructure, aiming to reduce import dependence and strengthen Indonesia's healthcare system.
#YonhapInfomax #SKPlasma #Danantara #BloodProducts #IndonesiaInvestmentAuthority #HealthcareInfrastructure #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=89991
SK Plasma Partners with Indonesia's Sovereign Wealth Fund Danantara for Blood Product Investment
SK Plasma has signed an MOU with Indonesia's sovereign wealth fund Danantara to invest in blood product manufacturing infrastructure, aiming to reduce import dependence and strengthen Indonesia's healthcare system.
SK Plasma Co. signed a 12 billion won ($8.7 million) investment MOU with Andong City to expand plasma storage and production infrastructure, aiming to stabilize blood product supply and boost the regional bio industry.
#YonhapInfomax #SKPlasma #AndongCity #PlasmaFractionation #InvestmentMOU #BloodProducts #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=72078
SK Plasma Signs 12 Billion Won Investment MOU with Andong City to Expand Plasma Fractionation Infrastructure
SK Plasma Co. signed a 12 billion won ($8.7 million) investment MOU with Andong City to expand plasma storage and production infrastructure, aiming to stabilize blood product supply and boost the regional bio industry.
SK Plasma and Aimed Bio have entered a joint development and licensing agreement to co-develop an ADC-based cancer drug, combining Aimed Bio's research with SK Plasma's clinical and commercialization expertise to target rare and intractable diseases.
#YonhapInfomax #SKPlasma #AimedBio #ADCTherapy #CancerDrug #Biopharmaceuticals #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=66632
SK Plasma Signs Joint Development Agreement with Aimed Bio for ADC-Based Cancer Drug
SK Plasma and Aimed Bio have entered a joint development and licensing agreement to co-develop an ADC-based cancer drug, combining Aimed Bio's research with SK Plasma's clinical and commercialization expertise to target rare and intractable diseases.
Yonhap Infomax News